Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.
Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
Elon Musk's chaotic appearance at CPAC on Thursday caused Google searches for the phrase "is Elon Musk on drugs" to spike the ...
After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...
In 2019, the FDA approved a ketamine-related chemical developed by Johnson & Johnson for severe depression. The drug, Spravato, is subject to strict FDA safety rules on where and how it can be ...
Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...
If esketamine seems familiar, that’s probably because it’s a component of ketamine. It was once popular as a party drug called Special K. Fortunately, Spravato underwent 31 clinical trials ...
The X-rated film star was referred to the facility in question on 27 January, 2024 to seek treatment for a 'ketamine addiction'. Advert According to a shocking lawsuit which has since been filed by ...
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with depression and suicidal thoughts- especially when anti-depressants and talk ...
The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results